AAAAAA

   
Results: 1-25 | 26-50 | 51-52
Results: 1-25/52

Authors: TURNER JG TAN J CRUCIAN BE SULLIVAN DM BALLESTER OF DALTON WS YANG NS BURKHOLDER JK YU H
Citation: Jg. Turner et al., BROADENED CLINICAL UTILITY OF GENE GUN-MEDIATED, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR CDNA-BASED TUMOR-CELL VACCINES AS DEMONSTRATED WITH A MOUSE MYELOMA MODEL, Human gene therapy, 9(8), 1998, pp. 1121-1130

Authors: MILLER TP CHASE EM DORR R DALTON WS LAM KS SALMON SE
Citation: Tp. Miller et al., A PHASE I II TRIAL OF PACLITAXEL FOR NON-HODGKINS-LYMPHOMA FOLLOWED BY PACLITAXEL PLUS QUININE IN DRUG-RESISTANT DISEASE/, Anti-cancer drugs, 9(2), 1998, pp. 135-140

Authors: TAYLOR CW GREEN S DALTON WS MARTINO S RECTOR D INGLE JN ROBERT NJ BUDD GT PARADELO JC NATALE RB BEARDEN JD MAILLIARD JA OSBORNE CK
Citation: Cw. Taylor et al., A MULTICENTER RANDOMIZED CLINICAL-TRIAL OF GOSERELIN VERSUS SURGICAL OVARIECTOMY IN PREMENOPAUSAL PATIENTS WITH RECEPTOR-POSITIVE METASTATIC BREAST-CANCER - AN INTERGROUP STUDY, Journal of clinical oncology, 16(3), 1998, pp. 994-999

Authors: HAZLEHURST LA GROS P DALTON WS
Citation: La. Hazlehurst et al., CHROMOSOME MEDIATED GENE-TRANSFER OF DRUG-RESISTANCE TO MITOXANTRONE, Anticancer research, 18(2A), 1998, pp. 1005-1010

Authors: KICKHOEFER VA RAJAVEL KS SCHEFFER GL DALTON WS SCHEPER RJ ROME LH
Citation: Va. Kickhoefer et al., VAULTS ARE UP-REGULATED IN MULTIDRUG-RESISTANT CANCER CELL-LINES, The Journal of biological chemistry, 273(15), 1998, pp. 8971-8974

Authors: LAMY T LIU JH LANDOWSKI TH DALTON WS LOUGHRAN TP
Citation: T. Lamy et al., DYSREGULATION OF FAS FAS LIGAND APOPTOTIC PATHWAY IN CD3+ LARGE GRANULAR LYMPHOCYTE (LGL) LEUKEMIA/, British Journal of Haematology, 102(1), 1998, pp. 278-278

Authors: DALTON WS
Citation: Ws. Dalton, ALTERNATIVE (NON-P-GLYCOPROTEIN) MECHANISMS OF DRUG-RESISTANCE IN NON-HODGKINS-LYMPHOMA, Hematology/oncology clinics of North America, 11(5), 1997, pp. 975

Authors: DALTON WS
Citation: Ws. Dalton, DETECTION OF MULTIDRUG-RESISTANCE GENE-EXPRESSION IN MULTIPLE-MYELOMA, Leukemia, 11(7), 1997, pp. 1166-1169

Authors: WATTS GS PIEPER RO COSTELLO JF PENG YM DALTON WS FUTSCHER BW
Citation: Gs. Watts et al., METHYLATION OF DISCRETE REGIONS OF THE O-6-METHYLGUANINE DNA METHYLTRANSFERASE (MGMT) CPG ISLAND IS ASSOCIATED WITH HETEROCHROMATINIZATION OF THE MGMT TRANSCRIPTION START SITE AND SILENCING OF THE GENE, Molecular and cellular biology, 17(9), 1997, pp. 5612-5619

Authors: CHAN HSL HADDAD G ZHENG L BRADLEY G DALTON WS LING V
Citation: Hsl. Chan et al., SENSITIVE IMMUNOFLUORESCENCE DETECTION OF THE EXPRESSION OF P-GLYCOPROTEIN IN MALIGNANT-CELLS, Cytometry, 29(1), 1997, pp. 65-75

Authors: TAYLOR CW DALTON WS MOSLEY K DORR RT SALMON SE
Citation: Cw. Taylor et al., COMBINATION CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, VINCRISTINE, ADRIAMYCIN, AND DEXAMETHASONE (CVAD) PLUS ORAL QUININE AND VERAPAMIL IN PATIENTS WITH ADVANCED BREAST-CANCER, Breast cancer research and treatment, 42(1), 1997, pp. 7-14

Authors: DALTON WS
Citation: Ws. Dalton, DRUG-RESISTANCE IN HEMATOLOGIC MALIGNANCIES - INTRODUCTION, Seminars in hematology, 34(4), 1997, pp. 1-2

Authors: DALTON WS
Citation: Ws. Dalton, MECHANISMS OF DRUG-RESISTANCE IN HEMATOLOGIC MALIGNANCIES, Seminars in hematology, 34(4), 1997, pp. 3-8

Authors: LANDOWSKI TH QU N BUYUKSAL I PAINTER JS DALTON WS
Citation: Th. Landowski et al., MUTATIONS IN THE FAS ANTIGEN IN PATIENTS WITH MULTIPLE-MYELOMA, Blood, 90(11), 1997, pp. 4266-4270

Authors: OSHIRO MH LANDOWSKI TH DALTON WS
Citation: Mh. Oshiro et al., INFLUENCE OF INTERLEUKIN-6 ON RESPONSE TO FAS AND CHEMOTHERAPEUTIC DRUG-INDUCED APOPTOSIS IN MYELOMA CELL-LINES, Blood, 90(10), 1997, pp. 2203-2203

Authors: DAMIANO J CRESS AE DALTON WS
Citation: J. Damiano et al., UP-REGULATION OF INTEGRIN VLA-4 IS ASSOCIATED WITH LOW-LEVEL DRUG-RESISTANCE IN HUMAN MYELOMA CELLS, Blood, 90(10), 1997, pp. 2206-2206

Authors: LANDOWSKI TH GLEASONGUZMAN MC DALTON WS
Citation: Th. Landowski et al., SELECTION FOR DRUG-RESISTANCE RESULTS IN RESISTANCE TO FAS-MEDIATED APOPTOSIS, Blood, 89(6), 1997, pp. 1854-1861

Authors: WANG H JIANG ZG WONG YW DALTON WS FUTSCHER BW CHAN VTW
Citation: H. Wang et al., DECREASED CP-1 (NF-Y) ACTIVITY RESULTS IN TRANSCRIPTIONAL DOWN-REGULATION OF TOPOISOMERASE II-ALPHA IN A DOXORUBICIN-RESISTANT VARIANT OF HUMAN MULTIPLE-MYELOMA RPMI-8226, Biochemical and biophysical research communications, 237(2), 1997, pp. 217-224

Authors: WITHERSPOON SM EMERSON DL KERR BM LLOYD TL DALTON WS WISSEL PS
Citation: Sm. Witherspoon et al., FLOW CYTOMETRIC ASSAY OF MODULATION OF P-GLYCOPROTEIN FUNCTION IN WHOLE-BLOOD BY THE MULTIDRUG-RESISTANCE INHIBITOR GG918, Clinical cancer research, 2(1), 1996, pp. 7-12

Authors: ANDERSON JM HEINDL LM BAUMAN PA LUDI CW DALTON WS CRESS AE
Citation: Jm. Anderson et al., CYTOKERATIN EXPRESSION RESULTS IN A DRUG-RESISTANT PHENOTYPE TO 6 DIFFERENT CHEMOTHERAPEUTIC-AGENTS, Clinical cancer research, 2(1), 1996, pp. 97-105

Authors: LEHNERT M DEGIULI R KUNKE K EMERSON S DALTON WS SALMON SE
Citation: M. Lehnert et al., SERUM CAN INHIBIT REVERSAL OF MULTIDRUG-RESISTANCE BY CHEMOSENSITIZERS, European journal of cancer, 32A(5), 1996, pp. 862-867

Authors: ZHAO S CONSOLI U ARCECI R PFEIFER J DALTON WS ANDREEFF M
Citation: S. Zhao et al., SEMIAUTOMATED PCR METHOD FOR QUANTITATING MDR1 EXPRESSION, BioTechniques, 21(4), 1996, pp. 726-731

Authors: SALMON SE DALTON WS
Citation: Se. Salmon et Ws. Dalton, RELEVANCE OF MULTIDRUG-RESISTANCE TO RHEUMATOID-ARTHRITIS - DEVELOPMENT OF A NEW THERAPEUTIC HYPOTHESIS, Journal of rheumatology, 23, 1996, pp. 97-101

Authors: SALMON SE DALTON WS
Citation: Se. Salmon et Ws. Dalton, MULTIDRUG-RESISTANCE IN RHEUMATOID-ARTHRITIS - REPLY, Journal of rheumatology, 23(12), 1996, pp. 2182-2182

Authors: VOGLER WR BERDEL WE WINTON EF GORDON DS GELLER RB HEFFNER LT BROCHSTEIN JA BEVERIDGE RA DALTON WS MILLER KB LAZARUS HM
Citation: Wr. Vogler et al., LONG-TERM FOLLOW-UP OF EDELFOSINE PURGING FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ACUTE-LEUKEMIA, Experimental hematology, 24(9), 1996, pp. 615-615
Risultati: 1-25 | 26-50 | 51-52